Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Putting on my TA hat...
View:
Post by mercedesman on Jan 12, 2022 12:20pm

Putting on my TA hat...

...I can confirm that we have had a testicular breakout in the last week

The upper bullinger bands were touched (but not in a particulalry painful way)

Some minor resistance expected at the ridiculously low AGP financing level of .425, but likely many of those shares ended up in stronger hands, after affording someone a handsome tax loss, and a bunch of left over candy (aka warrants)

Looking forward to getting through the next candy dispensing exercise, so that we can get on with the end-game.  To me, it looks more likely that the PMX pawn will be queened before the Dialco pawn.  But it depends on when they start "pushing the pawns"...vs having the king diddle around looking for Waldo (en).

MM
Comment by Domino55 on Jan 13, 2022 9:37am
When is the option handout? The obvious dilemma is whether, after significant clinical advancements, it is even ethical to accept them anywhere below last year's level, considering what has transpired since Seto took over as CEO. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities